Repare`s Lunresertib-Camonsertib Combo Shows Positive Ph 1 Results
12 Dec 2024 //
BUSINESSWIRE
Repare to Host Webcast on Lunresertib & Camonsertib Data
10 Dec 2024 //
BUSINESSWIRE
Repare Therapeutics Updates Safety Results from MYTHIC Trial
23 Oct 2024 //
BUSINESSWIRE
Repare Therapeutics Provides Business and Reports 2nd Quarter 2024
06 Aug 2024 //
BUSINESSWIRE
Repare Therapeutics shows Positive Data From Phase 1 MINOTAUR Trial At ESMO GI
26 Jun 2024 //
BUSINESSWIRE
Foundation Medicine, Repare Partner On Genomic Profiling, Companion Dx
12 Jun 2024 //
BUSINESSWIRE